Trial is under way for SynapDx's early autism test

05/10/2013 | American City Business Journals

SynapDx is conducting a clinical trial to test its blood-based assay in diagnosing autism in children 18 months or older. The trial, launched last month, involves 660 children at 20 clinical sites. The average age at which autism is detected is 4.5 years, and earlier detection would allow earlier treatment.

View Full Article in:

American City Business Journals

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA